CV · CapsoVision, Inc
$6.55
-0.05 (-0.76%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements. While the Company raised approximately $14 million in gross proceeds resulting from subsequent Private Placement described in Note 1. DESCRIPTION OF BUSINESS AND ORGANIZATIONAL STRUCTURE and further discussed in Note 9. COMMON STOCK, it is not probable that these funds are sufficient to fund expenditures necessary to achieve sales growth and innovation objectives. The Company intends to consummate additional capital raising activities, but there is no certainty as to such capital raising activities occurring at all, or occurring with sufficient timing or magnitude, sufficient to alleviate such substantial doubt.”View the 10-Q filed May 14, 2026
Market Cap
$324.26M
Shares
49.96M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-07-23 | Amendment | Biotechnology | $64,828,840 | $64,828,822 | 06b |
| 2023-10-19 | Amendment | Biotechnology | $54,828,841 | $54,828,812 | 06b |
| 2023-03-07 | Amendment | Biotechnology | $41,951,355 | $34,698,838 | 06b |
| 2021-03-11 | Amendment | Biotechnology | $20,000,000 | $11,996,358 | 06b |
| 2020-06-17 | New | Biotechnology | $5,470,000 | $980,000 | 06b |
Showing 1–5 of 5 filings